Literature DB >> 19110052

Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.

Y Rebecca Chin1, Alex Toker.   

Abstract

The serine/threonine protein kinase Akt is a major signal transducer of the phosphoinositide 3-kinase (PI 3-K) pathway in all cells and tissues and plays a pivotal role in the maintenance of cellular processes including cell growth, proliferation, survival and metabolism. The frequent aberrant activation of the PI 3-K/Akt pathway in human cancer has made it an attractive therapeutic target. Numerous studies have provided a comprehensive understanding of the specific functions of Akt signaling in cancer cells as well as the surrounding tumor microenvironment and this has informed and enabled the development of therapeutic drugs to target both PI 3-K and Akt. However, recent studies have provided evidence for distinct functions of the three mammalian Akt isoforms, particularly with respect to the regulation of cell motility and metastasis of breast cancer. Here we discuss the mechanisms by which Akt signaling contributes to invasive migration and tumor metastasis, and highlight recent advances in our understanding of the contribution of the Akt pathway in the tumor-associated stroma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110052      PMCID: PMC2719559          DOI: 10.1016/j.cellsig.2008.11.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  75 in total

1.  Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration.

Authors:  Guo-Lei Zhou; David F Tucker; Sun Sik Bae; Kanav Bhatheja; Morris J Birnbaum; Jeffrey Field
Journal:  J Biol Chem       Date:  2006-10-01       Impact factor: 5.157

2.  Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.

Authors:  Ioanna G Maroulakou; William Oemler; Stephen P Naber; Philip N Tsichlis
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Reconstruction of human mammary tissues in a mouse model.

Authors:  David A Proia; Charlotte Kuperwasser
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.

Authors:  George Z Cheng; Joseph Chan; Qi Wang; Weizhou Zhang; Calvin D Sun; Lu-Hai Wang
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

5.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Authors:  Antoine E Karnoub; Ajeeta B Dash; Annie P Vo; Andrew Sullivan; Mary W Brooks; George W Bell; Andrea L Richardson; Kornelia Polyak; Ross Tubo; Robert A Weinberg
Journal:  Nature       Date:  2007-10-04       Impact factor: 49.962

6.  Akt1 governs breast cancer progression in vivo.

Authors:  Xiaoming Ju; Sanjay Katiyar; Chenguang Wang; Manran Liu; Xuanmao Jiao; Shengwen Li; Jie Zhou; Jacob Turner; Michael P Lisanti; Robert G Russell; Susette C Mueller; John Ojeifo; William S Chen; Nissim Hay; Richard G Pestell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-25       Impact factor: 11.205

7.  CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.

Authors:  Zhongxing Liang; Joann Brooks; Margaret Willard; Ke Liang; Younghyoun Yoon; Seunghee Kang; Hyunsuk Shim
Journal:  Biochem Biophys Res Commun       Date:  2007-06-04       Impact factor: 3.575

8.  Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin.

Authors:  Tomoya Kitamura; Naoya Asai; Atsushi Enomoto; Kengo Maeda; Takuya Kato; Maki Ishida; Ping Jiang; Takashi Watanabe; Jiro Usukura; Takahisa Kondo; Frank Costantini; Toyoaki Murohara; Masahide Takahashi
Journal:  Nat Cell Biol       Date:  2008-02-10       Impact factor: 28.824

Review 9.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.

Authors:  John D Carpten; Andrew L Faber; Candice Horn; Gregory P Donoho; Stephen L Briggs; Christiane M Robbins; Galen Hostetter; Sophie Boguslawski; Tracy Y Moses; Stephanie Savage; Mark Uhlik; Aimin Lin; Jian Du; Yue-Wei Qian; Douglas J Zeckner; Greg Tucker-Kellogg; Jeffrey Touchman; Ketan Patel; Spyro Mousses; Michael Bittner; Richard Schevitz; Mei-Huei T Lai; Kerry L Blanchard; James E Thomas
Journal:  Nature       Date:  2007-07-04       Impact factor: 69.504

View more
  105 in total

Review 1.  Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin.

Authors:  Y Rebecca Chin; Alex Toker
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

2.  UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Authors:  Yanhong Luo; Jianfeng He; Chunlin Yang; Matthew Orange; Xingcong Ren; Nick Blair; Tao Tan; Jin-Ming Yang; Hua Zhu
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

3.  The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration.

Authors:  Y Rebecca Chin; Alex Toker
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

4.  Vascular endothelial growth factor receptor-2 activates ADP-ribosylation factor 1 to promote endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells.

Authors:  Zeinab Daher; Pierre-Luc Boulay; Fanny Desjardins; Jean-Philippe Gratton; Audrey Claing
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

5.  The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.

Authors:  Alex Kiepas; Elena Voorand; Julien Senecal; Ryuhjin Ahn; Matthew G Annis; Kévin Jacquet; George Tali; Nicolas Bisson; Josie Ursini-Siegel; Peter M Siegel; Claire M Brown
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

6.  MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

Authors:  Xiaolei Hu; Jie Wang; Wan He; Pan Zhao; Changsheng Ye
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

7.  PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.

Authors:  Ken Dabanaka; Suyoun Chung; Hidewaki Nakagawa; Yusuke Nakamura; Takehiro Okabayashi; Takeki Sugimoto; Kazuhiro Hanazaki; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

8.  Kaposi sarcoma-associated herpesvirus g protein-coupled receptor enhances endothelial cell survival in part by upregulation of bcl-2.

Authors:  Elizabeth R Abboud; Bryan D Shelby; Magdalena Angelova; Anne B Nelson; Marybeth Ferris; Harris E McFerrin; Cindy A Morris; Deborah E Sullivan
Journal:  Ochsner J       Date:  2013

9.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375

10.  Factor XII and uPAR upregulate neutrophil functions to influence wound healing.

Authors:  Evi X Stavrou; Chao Fang; Kara L Bane; Andy T Long; Clément Naudin; Erdem Kucukal; Agharnan Gandhi; Adina Brett-Morris; Michele M Mumaw; Sudeh Izadmehr; Alona Merkulova; Cindy C Reynolds; Omar Alhalabi; Lalitha Nayak; Wen-Mei Yu; Cheng-Kui Qu; Howard J Meyerson; George R Dubyak; Umut A Gurkan; Marvin T Nieman; Anirban Sen Gupta; Thomas Renné; Alvin H Schmaier
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.